Bank of America’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$470K Sell
29,164
-14
-0% -$367 ﹤0.01% 4930
2025
Q4
$588K Hold
29,178
﹤0.01% 4829
2025
Q3
$252K Sell
29,178
-100
-0.3% -$716 ﹤0.01% 6164
2025
Q2
$92.5K Sell
29,278
-18
-0.1% -$56 ﹤0.01% 6554
2025
Q1
$132K Hold
29,296
﹤0.01% 6367
2024
Q4
$198K Buy
29,296
+18
+0.1% +$83 ﹤0.01% 6128
2024
Q3
$95.6K Sell
29,278
-18
-0.1% -$99 ﹤0.01% 6335
2024
Q2
$189K Buy
29,296
+9
+0% +$69 ﹤0.01% 5914
2024
Q1
$213K Sell
29,287
-6
-0% -$50 ﹤0.01% 5853
2023
Q4
$272K Buy
29,293
+13
+0% +$120 ﹤0.01% 5894
2023
Q3
$284K Sell
29,280
-22
-0.1% -$343 ﹤0.01% 5692
2023
Q2
$630K Sell
29,302
-422
-1% -$11.2K ﹤0.01% 5111
2023
Q1
$835K Sell
29,724
-1
-0% -$30 ﹤0.01% 5021
2022
Q4
$669K Sell
29,725
-289
-1% -$6.59K ﹤0.01% 5169
2022
Q3
$718K Buy
30,014
+7,409
+33% +$239K ﹤0.01% 5117
2022
Q2
$657K Buy
22,605
+22,379
+9,902% +$999K ﹤0.01% 5238
2022
Q1
$21K Sell
226
-687
-75% -$59.7K ﹤0.01% 7495
2021
Q4
$87K Sell
913
-7,268
-89% -$995K ﹤0.01% 6940
2021
Q3
$1.46M Buy
8,181
+1,077
+15% +$239K ﹤0.01% 4725
2021
Q2
$2.09M Buy
7,104
+3,806
+115% +$1.13M ﹤0.01% 4276
2021
Q1
$888K Buy
3,298
+3,137
+1,948% +$955K ﹤0.01% 4935
2020
Q4
$37K Buy
161
+148
+1,138% +$39.7K ﹤0.01% 6428
2020
Q3
$3K Buy
+13
New +$3.08K ﹤0.01% 6648

Other funds holding BNR

Bank of America's BNR Position: Q1 2026 in Review

Bank of America reduced its Burning Rock Biotech (BNR) stake by 0.05% in Q1 2026, selling an estimated $367 and leaving 29,164 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #4930.

Bank of America first reported a position in BNR in Q3 2020 and has held it in 23 quarters since. The position peaked at $2.09M in Q2 2021. 16 funds tracked by Wall St. Rank hold BNR as of Q1 2026.

  • Bank of America held 29,164 shares of Burning Rock Biotech worth $470K as of Q1 2026.
  • Bank of America sold 14 Burning Rock Biotech shares in Q1 2026, an estimated $367.
  • Burning Rock Biotech made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4930 holding.
  • Bank of America first reported a position in Burning Rock Biotech in Q3 2020 and has held it in 23 quarters since.
  • Bank of America's Burning Rock Biotech position peaked at $2.09M in Q2 2021.
  • 16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.